{"nct_id":"NCT02393859","title":"Phase 3 Trial of Blinatumomab vs Standard Chemotherapy in Pediatric Subjects With HIgh-Risk (HR) First Relapse B-precursor Acute Lymphoblastic Leukemia (ALL)","status":"COMPLETED","status_verified_date":"2024-05","start_date":"2015-11-10","start_date_type":"ACTUAL","primary_completion_date":"2019-07-17","primary_completion_date_type":"ACTUAL","completion_date":"2022-11-21","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["AMGN"]}